| Q41114284 | 3-D Electrochemical Impedance Spectroscopy Mapping of Arteries to Detect Metabolically Active but Angiographically Invisible Atherosclerotic Lesions. |
| Q57058252 | 40 Years of Percutaneous Coronary Intervention: History and Future Directions |
| Q61614920 | A NEW TREATMENT FOR URETHRAL STRICTURES |
| Q54263160 | A comparison study of self-expandable stents vs balloon angioplasty alone in femoropopliteal artery occlusions. |
| Q43092679 | A genome wide association analysis in the GENDER study. |
| Q35532916 | A genome-wide association study identifies a region at chromosome 12 as a potential susceptibility locus for restenosis after percutaneous coronary intervention |
| Q47976079 | A good alternative to indwelling catheter owing to benign prostate hyperplasia in elderly: Memotherm prostatic stent |
| Q40718312 | A method for investigating the mechanical properties of intracoronary stents using finite element numerical simulation |
| Q68050077 | A new intratracheal stent for tracheobronchial reconstruction: experimental and clinical studies |
| Q72375479 | A new self-expandable, nickel-titanium coil stent for esophageal obstruction: a preliminary report |
| Q84170380 | A novel in vitro model for preclinical testing of the hemocompatibility of intravascular stents according to ISO 10993-4 |
| Q73448707 | A numerical and experimental study of periodic flow in a model of a corrugated vessel with application to stented arteries |
| Q77361791 | A randomized trial comparing the hand-mounted JoStent with the premounted Multi-Link Duet stent in patients with coronary artery disease |
| Q67790541 | A solution to the problem of an unexpanded palmaz-schatz stent following balloon rupture |
| Q58976304 | ACC expert consensus document on coronary artery stents |
| Q38573540 | Absorb bioresorbable stents for the treatment of coronary artery disease |
| Q73851131 | Acute and 30-day results of the serpentine balloon expandable stent implantation in simple and complex coronary arterial narrowings |
| Q28189014 | Acute and 6-month clinical and angiographic outcome after implantation of the ACS Duet stent for single-vessel coronary artery disease: final results of the European and US ACS Multi-link Duet Registry |
| Q44372733 | Acute stent thrombosis after early withdrawal of platelet glycoprotein IIb/IIIa antagonists: potential rebound prothrombotic effect? |
| Q70053051 | Additional improvement of stenosis geometry in human coronary arteries by stenting after balloon dilatation |
| Q40589648 | Adjunctive thrombolytic agents with coronary interventional techniques. |
| Q33997462 | Advances in interventional cardiology |
| Q74197388 | An introduction to provisional stenting |
| Q34581393 | Analysis of a phosphorylcholine-based polymer coating on a coronary stent pre- and post-implantation |
| Q30627348 | Angiographic and clinical one-year follow-up of the Cordis tantalum coil stent in a multicenter international study demonstrating improved restenosis rates when compared to pooled PTCA and BENESTENT-I data: the European Antiplatelet Stent Investigat |
| Q68215069 | Angiographic and clinical outcome of intracoronary stenting: Immediate and long-term results from a large single-center experience |
| Q74794910 | Angioplasty in the stent era: results of a consecutive series of patients undergoing coronary angioplasty without surgical backup |
| Q72341506 | Angioplasty with stent placement in peripheral arterial occlusive disease |
| Q52593614 | Antiplatelet Therapy in Coronary Artery Disease: A Daunting Dilemma. |
| Q73249498 | Antiplatelet rather than anticoagulant therapy with coronary stenting |
| Q36941850 | Antiplatelet therapy in the era of drug-eluting stents: current and future perspectives |
| Q28174946 | Antithrombotic therapy in cardiac stent patients |
| Q46860463 | Aortoiliac stent deployment versus surgical reconstruction: analysis of outcome and cost. |
| Q37384737 | Application of intraluminal ultrasound imaging to vascular stenting |
| Q59809026 | Applying DESyne coronary stent system in patients with ischemic heart disease: experience from Jordan |
| Q50909136 | Are common leptin promoter polymorphisms associated with restenosis after coronary stenting? |
| Q68587521 | Arterial stenting with self-expandable and balloon-expandable endoprostheses |
| Q73727777 | Assessment of a polyester-covered nitinol stent in an atherosclerotic swine model |
| Q46184650 | Assessment of wrought ASTM F1058 cobalt alloy properties for permanent surgical implants |
| Q73103631 | Autologous vein graft-coated stents for the treatment of thrombus-containing coronary artery lesions |
| Q39387227 | Automated extraction, labelling and analysis of the coronary vasculature from arteriograms |
| Q74379769 | Bacteraemia complicating coronary artery stenting |
| Q35868161 | Balloon Angioplasty - The Legacy of Andreas Grüntzig, M.D. (1939-1985) |
| Q77202009 | Balloon angioplasty, stenting, and role of atherectomy |
| Q46185910 | Balloon catheter retrieval of dislodged coronary artery stents: a novel technique |
| Q69208207 | Balloon dilatation and insertion of a self-expandable flexible metallic stent in a benign stricture of the left hepatic duct: case report |
| Q38147613 | Balloon dilation catheters |
| Q37707419 | Benefits of and safety concerns associated with drug-eluting coronary stents |
| Q32000876 | Beyond stents: third-generation coronary devices |
| Q47224597 | Bio-Functional Design, Application and Trends in Metallic Biomaterials |
| Q45061142 | Bioabsorbable Scaffolds: Can the Problems of Dissolution Be Overcome? |
| Q37663672 | Bioabsorbable stent quo vadis: a case for nano-theranostics |
| Q42232032 | Biocompatibility of Coronary Stents |
| Q46042716 | Biocompatibility of fluoride-coated magnesium-calcium alloys with optimized degradation kinetics in a subcutaneous mouse model |
| Q26864540 | Biodegradable polymer Biolimus-eluting stent (Nobori®) for the treatment of coronary artery lesions: review of concept and clinical results |
| Q35989727 | Biomedical therapy using synthetic WKYMVm hexapeptide |
| Q35939015 | Biomimetic actuators: where technology and cell biology merge |
| Q88196124 | Bioresorbable Scaffolds |
| Q39097196 | Bioresorbable Scaffolds for Coronary Artery Disease |
| Q36055029 | Bioresorbable Stents in PCI. |
| Q38172353 | Bioresorbable drug-eluting magnesium-alloy scaffold for treatment of coronary artery disease |
| Q38728978 | Bioresorbable drug-eluting scaffolds for treatment of vascular disease |
| Q27690259 | Bioresorbable scaffolds: rationale, current status, challenges, and future |
| Q41860479 | Bioresorbable vascular scaffolds-time to vanish? |
| Q34981345 | CDKs and CKIs: molecular targets for tissue remodelling |
| Q39549561 | CT Imaging of Coronary Stents: Past, Present, and Future |
| Q37689032 | Call for standards in technical documentation of intracoronary stents |
| Q36826022 | Can early closure and restenosis after endoluminal stenting be predicted from clinical, procedural, and angiographic variables at the time of intervention? |
| Q40973178 | Cardiovascular applications of biomaterials and implants--an overview |
| Q58752931 | Cardiovascular stents: overview, evolution, and next generation |
| Q50961835 | Carotid stenting: looking beyond the degree of carotid stenosis. |
| Q71011565 | Case report: pulmonary arterial obstruction caused by recurrent tumour treated with endovascular stenting |
| Q38381419 | Causes, assessment, and treatment of stent thrombosis--intravascular imaging insights |
| Q56945586 | Caveats about Elective Coronary Stenting |
| Q54206325 | Changes in arterial wall compliance after endovascular stenting. |
| Q36835991 | Changing from intensive anticoagulation to treatment with aspirin alone for coronary stents: the experience of one centre in the United Kingdom |
| Q38194095 | Choosing the right coronary stent in the modern era. |
| Q73199234 | Clinical and angiographic implications of coronary stenting in thrombus-containing lesions |
| Q73200608 | Clinical and angiographic outcomes are similar with half, single, or multiple contiguous Palmaz-Schatz stent implantations for a single coronary stenosis |
| Q51827570 | Clinical and angiographic results of coronary artery stenting using PURA-VARIO (PUVA) stents. |
| Q58181715 | Clinical and quantitative angiographic outcomes following elective implantation of the self-expanding Wallstent for longer coronary artery lesions--final results of the Wellstent native study |
| Q33614133 | Clinical experience with the Wiktor stent in native coronary arteries and coronary bypass grafts |
| Q38059616 | Clinical impact of genetically determined platelet reactivity |
| Q35095505 | Clinicians' contributions to the development of coronary artery stents: a qualitative study of transformative device innovation |
| Q37605466 | Clopidogrel before elective percutaneous coronary intervention |
| Q34030132 | Clopidogrel: a review of its use in the prevention of atherothrombosis |
| Q48578599 | Common sense and figures: the rhetoric of validity in medicine (Bradford Hill Memorial Lecture 1999). |
| Q47964161 | Comparison of a new polytetrafluoroethylene-covered metallic stent to a noncovered stent in canine ureters |
| Q71244211 | Comparison of elective Wiktor stent placement with conventional balloon angioplasty for new-onset lesions of the right coronary artery |
| Q73031104 | Comparison of the efficacy and safety of aspirin alone with coumadin plus aspirin after provisional coronary stenting: final and follow-up results of a randomized study |
| Q45751067 | Compassionate use of a paclitaxel coated balloon in patients with refractory recurrent coronary in-stent restenosis |
| Q71764992 | Complications of iliac artery stent deployment |
| Q61439470 | Continued expansion of the nitinol self-expanding coronary stent: Angiographic analysis and 1-year clinical follow-up |
| Q34079560 | Controlled release for local delivery of drugs: barriers and models |
| Q38894798 | Coronary Artery Revascularisation : Past, Present and Future |
| Q38565074 | Coronary Stents: The Impact of Technological Advances on Clinical Outcomes. |
| Q36553520 | Coronary arterial revascularization: past, present, future: part I--historical trials. |
| Q51801837 | Coronary artery and myocardial inflammatory reaction induced by intracoronary stent. |
| Q51084050 | Coronary artery bypass grafting: long-term psychological and social outcomes. |
| Q40611517 | Coronary artery stent infection. |
| Q35371650 | Coronary artery stenting in unstable angina pectoris: a comparison with stable angina pectoris |
| Q73964100 | Coronary artery stenting without anticoagulation, aspirin, ultrasound guidance, or high balloon pressure: prospective study of 1,051 consecutive patients |
| Q38287152 | Coronary artery stents: advances in technology. |
| Q33795842 | Coronary artery stents: appropriate use of adjunctive pharmacotherapy to prevent stent thrombosis |
| Q36210179 | Coronary artery stents: identification and evaluation. |
| Q52537599 | Coronary balloon angioplasty, stents, and scaffolds. |
| Q42056533 | Coronary implantation of silicone-carbide-coated Palmaz-Schatz stents in patients with high risk of stent thrombosis without oral anticoagulation |
| Q71551125 | Coronary lumen at six-month follow-up of a new radiopaque Cordis tantalum stent using quantitative angiography and intracoronary ultrasound |
| Q33802871 | Coronary microembolization--its role in acute coronary syndromes and interventions |
| Q37862930 | Coronary revascularization: 2011. |
| Q33546219 | Coronary stent implantation in acute myocardial infarction |
| Q36514842 | Coronary stent thrombosis: current insights into new drug-eluting stent designs |
| Q71126019 | Coronary stenting in patients undergoing percutaneous transluminal coronary angioplasty during acute myocardial infarction |
| Q39412374 | Coronary stenting through 6 French guiding catheters |
| Q46688830 | Coronary stenting with angioscopic guidance |
| Q42392328 | Coronary stenting: has the rubicon been crossed? |
| Q41057555 | Coronary stents and vascular response to implantation: literature review |
| Q38093501 | Coronary stents: historical development, current status and future directions |
| Q74808938 | Coronary wallstents show significant late, postprocedural expansion despite implantation with adjunct high-pressure balloon inflations |
| Q36204864 | Cost-effectiveness modelling of percutaneous coronary interventions in stable coronary artery disease |
| Q48014828 | Crush Deformation of a Balloon-Expandable Stent Implanted in an Infrainguinal Bypass Graft |
| Q37558450 | Current issues in coronary stent technology |
| Q38572024 | Current status of biodegradable stents. |
| Q39506203 | Delayed coronary occlusion following primary successful angioplasty: Management and outcome |
| Q72790225 | Deposition of platelets and neutrophils in porcine iliac arteries after angioplasty and Wallstent placement compared with angioplasty alone |
| Q42081515 | Determinants of myocardial infarction following emergency coronary artery bypass for failed percutaneous coronary angioplasty |
| Q38592886 | Development and application of metal materials in terms of vascular stents. |
| Q34440106 | Development and characterization of a coronary polylactic acid stent prototype generated by selective laser melting |
| Q44551925 | Development of a temperature sensitive drug release system for polymeric implant devices |
| Q50915079 | Development of in vivo tissue-engineered autologous tissue-covered stents (biocovered stents). |
| Q33781183 | Diagnosis and management of patients with unstable angina |
| Q52917330 | Direct coronary stenting without predilation. |
| Q77682010 | Directional atherectomy in iliac stent failure: clinical technique and histopathologic correlation |
| Q67790566 | Do stents interfere with the densitometric assessment of a coronary artery lesion? |
| Q73156951 | Does angiography six months after coronary intervention influence management and outcome? Benestent II Investigators |
| Q33941329 | Double stent loss during multivessel percutaneous coronary intervention in non-ST-segment elevation acute coronary syndrome |
| Q39008645 | Drug eluting stents: To evolve or dissolve? |
| Q38485348 | Drug release from a chemically-anchored PEG/phospholipid monolayer onto polymer-coated metallic stents |
| Q37633078 | Drug- and Gene-eluting Stents for Preventing Coronary Restenosis |
| Q38132036 | Drug-coated balloons for treatment of coronary artery disease: updated recommendations from a consensus group. |
| Q44612609 | Drug-delivering coronary artery stents: bare metal threatened by extinction? |
| Q37737338 | Drug-eluting balloon: new tool in the box. |
| Q37668357 | Drug-eluting stent coatings |
| Q34091036 | Drug-eluting stents |
| Q44561599 | Drug-eluting stents in complex lesions |
| Q37577872 | Drug-eluting stents in percutaneous coronary intervention: a benefit-risk assessment |
| Q35945466 | Drug-eluting stents: a mechanical and pharmacologic approach to coronary artery disease |
| Q35218995 | Drug-eluting stents: from bench to bed. |
| Q42167167 | Drug-eluting stents: implications for surgery patients |
| Q36884413 | Drug-eluting stents: trading restenosis for thrombosis? |
| Q93382621 | Dual antiplatelet therapy does not affect the incidence of low-dose aspirin-induced small intestinal mucosal injury in patients after percutaneous coronary intervention for coronary stenosis: a multicenter cross-sectional study |
| Q30252011 | Dual pathway therapy in acute coronary syndrome |
| Q67898594 | Early Experience with the Palmaz Expandable Intraluminal Stent in Iliac Artery Stenosis |
| Q41774907 | Early outcome after placement of a metallic intracoronary stent: initial Mayo Clinic experience |
| Q51784230 | Effect of hydrion evolution by polylactic-co-glycolic acid coating on degradation rate of pure iron. |
| Q51810179 | Effect of hydrion evolution by polylactic-co-glycolic acid coating on degradation rate of pure iron. |
| Q37267458 | Effects of Methotrexate in a Rabbit Model of In-Stent Neoatherosclerosis: An Optical Coherence Tomography Study. |
| Q44722086 | Effects of surgical manipulation on coronary stents: should surgical strategy be altered? |
| Q26801463 | Elective Urological Surgery Following Coronary Stent Implantation: To Whom, How To Do It? |
| Q80528980 | Electrochemical and microstructural studies of tantalum and its oxide films for biomedical applications in endovascular surgery |
| Q45285248 | Electromagnetic field focusing probe (EFFP)--a new angioplasty tool |
| Q77713734 | Electron-beam CT in the noninvasive assessment of coronary stent patency |
| Q47862043 | Eluting characteristics of a platelet glycoprotein receptor antibody using a PLLA-coated stent. |
| Q42773409 | Emergency cardiac surgery after a failed percutaneous coronary intervention in an interventional centre without on-site cardiac surgery |
| Q41336123 | Emergency coronary artery stenting for coronary dissection complicating diagnostic cardiac catheterisation |
| Q33839384 | Emerging applications of nanotechnology for the diagnosis and management of vulnerable atherosclerotic plaques |
| Q35369275 | Endoluminal vessel reconstruction by stent placement in patients with obstructive coronary artery disease who are poor surgical candidates |
| Q70118773 | Endoscopic evacuation of hematobilia induced by large bore self-expanding biliary mesh stent |
| Q71625839 | Endovascular graft placement for a symptomatic iatrogenic peroneal arteriovenous fistula |
| Q41356276 | Endovascular stents in the arterial system--current status |
| Q38558885 | Endovascular stents: a 'break through technology', future challenges |
| Q40913071 | Endovascular stents: preliminary clinical results and future developments |
| Q35346066 | Endovascular surgery for peripheral arterial occlusive disease. A critical review |
| Q77456216 | EsophaCoil: long-term results in 81 patients |
| Q90451021 | Evaluation of Mechanical Performances of Stents with 38 mm Length in Long Lesion |
| Q37993868 | Everolimus-eluting ABSORB bioresorbable vascular scaffold: present and future perspectives |
| Q43493349 | Exercise training is safe after coronary stenting: a prospective multicentre study |
| Q36287186 | Expandable Wallstent for the treatment of obstruction of the superior vena cava |
| Q67674479 | Expandable biliary metal stents for malignancies: endoscopic insertion and diathermic cleaning for tumor ingrowth |
| Q47253395 | Experience with paclitaxel-eluting Infinnium coronary stents. |
| Q40656472 | Experience with the Gianturco-Roubin stent for abrupt vessel closure complicating percutaneous transluminal coronary angioplasty |
| Q38628642 | Extracting information from free-text electronic patient records to identify practice-based evidence of the performance of coronary stents |
| Q44633720 | Fabrication of drug-eluting covered stents with micropores and differential coating of heparin and FK506 |
| Q41217415 | Fatal infection of coronary stent implantation |
| Q42050001 | Favorable impact of stents after emergent coronary artery bypass for failed angioplasty |
| Q45156039 | Fe-Au and Fe-Ag composites as candidates for biodegradable stent materials. |
| Q52867620 | Feasibility and applicability of coronary stent implantation with the direct brachial approach: results of a single-center study. |
| Q55018995 | Fifty years of coronary artery bypass grafting. |
| Q34660922 | Fighting restenosis after coronary angioplasty: contemporary and future treatment options |
| Q42055515 | First international new intravascular rigid-flex endovascular stent study (FINESS): clinical and angiographic results after elective and urgent stent implantation. The FINESS Trial Investigators |
| Q46886921 | Flow support catheter for prolonged maintenance of coronary blood flow |
| Q24524277 | Fortnightly review: Intracoronary stents |
| Q36982115 | Genetic risk factors for restenosis after percutaneous coronary intervention in Kazakh population. |
| Q41848765 | Global revascularization. |
| Q70062970 | Grading for angioplasty |
| Q71948906 | Guidance of anticoagulation after intracoronary implantation of palmaz-schatz stents by monitoring prothrombin and prothrombin fragment 1 + 2 |
| Q53509739 | Haplotypes of the angiotensin-converting enzyme (ACE) gene are associated with coronary artery disease but not with restenosis after coronary stenting. |
| Q36919252 | High technology in medicine: lessons from cardiovascular innovations and future perspective |
| Q41108979 | Historical overview on the development and characteristics of stents and future outlooks |
| Q77144064 | Hospital outcome after bailout coronary stenting in patients with acute myocardial infarction |
| Q37973296 | Impact of metabolic syndrome on re-stenosis development: role of drug-eluting stents |
| Q35369454 | Impact of stenting on coronary angioplasty procedures |
| Q33580902 | Impact of the "stent-when-feasible" policy on in-hospital and 6-month success and complication rates after coronary angioplasty: single-center experience with 17,956 revascularization procedures (1993-1997). |
| Q71921629 | Implantation of the peripheral Wallstent for diffuse lesions in coronary arteries and vein grafts |
| Q72056254 | Improvement of coronary morphology and blood flow after stenting. Assessment by intravascular ultrasound and intracoronary Doppler |
| Q35769824 | In stent restenosis: bane of the stent era. |
| Q53514457 | In vitro and in vivo corrosion properties of new iron-manganese alloys designed for cardiovascular applications. |
| Q50518424 | In vitro cytotoxicity and in vivo biocompatibility of poly(propylene fumarate-co-ethylene glycol) hydrogels. |
| Q51567851 | In vivo evaluation of a fluorine-acryl-stylene-urethane-silicone antithrombogenic coating material copolymer for intravascular stents. |
| Q35566928 | Incidence, recurrence, and case fatality rates for myocardial infarction in southwestern France, 1985 to 1993 |
| Q33649967 | Infection of endovascular stents: an uncommon but important complication |
| Q38445358 | Influence of a paclitaxel coated balloon in combination with a bare metal stent on restenosis and endothelial function: comparison with a drug eluting stent and a bare metal stent |
| Q77408079 | Influence of stent length and heparin coating on platelet activation: a flow cytometric analysis in a pulsed floating model |
| Q35070955 | Influence of the angiotensin converting enzyme insertion or deletion genetic variant and coronary restenosis risk: evidence based on 11,193 subjects |
| Q35937671 | Initial and late results of Freedom coronary stent |
| Q30775028 | Initial and long-term results with the CrossFlex stent--data from a national registry |
| Q35641591 | Initial clinical experience with an endoluminal spiral prosthesis for treating complicated venous thrombosis and preventing pulmonary embolism |
| Q74263237 | Initial clinical experience with the new EBI (BARD-XT) flexible coronary stent: acute results and follow-up |
| Q43657272 | Initial clinical results with the Wiktor stent: a new balloon-expandable coronary stent |
| Q30677842 | Initial results and 6 month clinical follow-up after implantation of a silicon carbide coated coronary stent |
| Q77769397 | Initial results and long-term clinical and angiographic implications of coronary stenting in elderly patients |
| Q58253564 | Initial results and long-term clinical follow-up of an amorphous hydrogenated silicon-carbide-coated stent in daily practice |
| Q58088650 | Initial single-center experience with a new intracoronary stent |
| Q39489418 | Interventional cardiac procedures in neonates and infants: state of the art. |
| Q38886151 | Interventional cardiology, where real life and science do not necessarily meet |
| Q41177133 | Interventional catheterization for congenital cardiac defects |
| Q39485774 | Interventional catheterization in pediatric congenital and acquired heart disease |
| Q37366586 | Interventional radiology of the lower urinary tract and its relationship to surgical treatment |
| Q35369510 | Intracoronary Multi-link stents: experience in 218 patients using aspirin alone |
| Q72034081 | Intracoronary Radiation Before Stent Implantation Inhibits Neointima Formation in Stented Porcine Coronary Arteries |
| Q47573724 | Intracoronary stenting--hope or hype? |
| Q33612010 | Intracoronary stents |
| Q71696152 | Intracoronary stents |
| Q37969814 | Intracranial stents for treatment of acute ischemic stroke: evolution and current status |
| Q74536111 | Intraureteral metallic endoprosthesis in the treatment of ureteral strictures |
| Q72617347 | Intravascular stenting following bypass grafting in terminal coronary artery disease |
| Q35475971 | Intravascular stenting: from basic research to clinical application |
| Q38738296 | Intravascular stents. |
| Q43085180 | Intravascular stents: a new technique for tissue processing for histology, immunohistochemistry, and transmission electron microscopy. |
| Q71977992 | Intravascular ultrasound after low and high inflation pressure coronary artery stent implantation |
| Q36412659 | Is there an alternative to systemic anticoagulation, as related to interventional biomedical devices? |
| Q34016822 | Lack of effect of warfarin on the restenosis rate or on clinical outcome after balloon coronary angioplasty |
| Q35298012 | Laser ablation and the need for intra-arterial imaging |
| Q77430550 | Late coronary artery stenting in patients with acute myocardial infarction |
| Q41343870 | Lesions I don't stent |
| Q51765595 | Linear Micro-patterned Drug Eluting Balloon (LMDEB) for Enhanced Endovascular Drug Delivery. |
| Q40080413 | Living history of medicine: vascular scaffolding, from dream to reality |
| Q64376863 | Local adventitial anti-angiogenic gene therapy reduces growth of vasa-vasorum and in-stent restenosis in WHHL rabbits |
| Q52872863 | Local paclitaxel induces late lumen enlargement in coronary arteries after balloon angioplasty. |
| Q37464405 | Local sustained delivery of acetylsalicylic acid via hybrid stent with biodegradable nanofibers reduces adhesion of blood cells and promotes reendothelialization of the denuded artery |
| Q71606924 | Long-term (4- to 6-year) outcome of Palmaz-Schatz stenting: paucity of late clinical stent-related problems |
| Q24792495 | Long-term outcome after coronary stenting |
| Q71297243 | Long-term patency of metallic stents in 20-year-old saphenous vein coronary bypass graft |
| Q38153786 | Long-term safety of drug-eluting stents |
| Q38085209 | MDCT coronary angiography -- postprocessing, reading, and reporting: last but not least. |
| Q30305538 | Management of Acute Ischemic Coronary Syndromes: The Present and Future |
| Q34378497 | Management of common bile duct stricture caused by chronic pancreatitis with metal mesh self expandable stents |
| Q74672850 | Management of iliac occlusions with a new self-expanding endovascular stent |
| Q37523435 | Materials for metallic stents |
| Q37073779 | Materials, fluid dynamics, and solid mechanics aspects of coronary artery stents: a state-of-the-art review |
| Q35594821 | Mechanical behavior of fully expanded commercially available endovascular coronary stents |
| Q72238840 | Mechanical features and in vivo imaging of a polymer stent |
| Q44913182 | Metallic self-expanding stent application in the upper gastrointestinal tract: caveats and concerns |
| Q26775547 | MicroRNAs and Endothelial (Dys) Function |
| Q44782574 | Midterm results of renal artery stenting |
| Q68026189 | Monitoring prothrombin fragment 1 + 2 during initiation of oral anticoagulant therapy after intracoronary stenting |
| Q46198020 | Morphologic change in coronary artery stenosis with the medtronic Wiktor™ stent: Initial results from the core laboratory for quantitative angiography |
| Q92867169 | Multi-objective optimisation of material properties and strut geometry for poly(L-lactic acid) coronary stents using response surface methodology |
| Q58147212 | Multicenter evaluation of the phosphorylcholinecoated biodivYsio stent in short de novo coronary lesions: The SOPHOS study |
| Q54763757 | Neoatherosclerosis and Late Thrombosis After Percutaneous Coronary Intervention: Translational Cardiology and Comparative Medicine from Bench to Bedside. |
| Q26774540 | Neoatherosclerosis: Coronary stents seal atherosclerotic lesions but result in making a new problem of atherosclerosis |
| Q72428623 | Neointima formation following arterial placement of self-expanding stents of different radial force: experimental results |
| Q36686682 | New devices in interventional cardiology: a European perspective |
| Q38561699 | New stent technologies |
| Q43005673 | Ni-Cr-Co alloy ureteral stent: scanning electron microscopy and elemental analysis characterization after long-term indwelling |
| Q40945835 | Nitric oxide donors: a continuing opportunity in drug design. |
| Q41139312 | Noncoronary vascular stenting |
| Q38235041 | Novel potential targets for prevention of arterial restenosis: insights from the pre-clinical research. |
| Q83207662 | Novel stents for the prevention of restenosis |
| Q38188593 | Novel technologies in the treatment of intracranial aneurysms |
| Q39754135 | Opportunities and limitations of drug-coated balloons in interventional therapies |
| Q52304778 | Optimized expansion of the Wallstent compared with the Palmaz-Schatz stent: on-line observations with two- and three-dimensional intracoronary ultrasound after angiographic guidance. |
| Q31073668 | Options for percutaneous coronary and peripheral revascularization |
| Q51112819 | Oral mycophenolate mofetil prevents in-stent intimal hyperplasia without edge effect. |
| Q33342861 | Outcome of extensive coronary artery dissection during coronary angioplasty |
| Q34544955 | Overcoming restenosis with sirolimus: from alphabet soup to clinical reality |
| Q41743529 | Pathobiologic responses to stenting |
| Q42167155 | Patients with coronary artery stents: when and how should operations be carried out? |
| Q67871489 | Percutaneous Placement of a Balloon-expandable Intraluminal Graft for Life-threatening Subclavian Arterial Hemorrhage |
| Q33322264 | Percutaneous Transluminal Angioplasty of the Lower Extremities by the Vascular Surgeon |
| Q47763813 | Percutaneous coronary intervention in the elderly: are drug coated balloons the future? |
| Q90433507 | Percutaneous coronary intervention: balloons, stents and scaffolds |
| Q35575681 | Percutaneous coronary intervention: historical perspectives, current status, and future directions |
| Q37900509 | Percutaneous coronary interventions in facilities without cardiac surgery on site |
| Q48601912 | Percutaneous coronary rotational angioplasty: Preliminary clinical and quantitative imaging results |
| Q33287582 | Percutaneous endovascular stenting: development, investigation and application |
| Q72285698 | Percutaneous implantation of autologous vein graft stent for treatment of coronary artery disease |
| Q39514297 | Percutaneous placement of a hepatic vein stent in the treatment of Budd-Chiari syndrome |
| Q68366336 | Percutaneous portal-systemic shunts: Promise and problems |
| Q71876544 | Percutaneous transluminal coronary angioplasty in refractory unstable angina pectoris: are new devices useful? |
| Q41589979 | Percutaneous transluminal coronary angioplasty or coronary artery bypass grafting for coronary artery disease? |
| Q33610961 | Percutaneous transluminal coronary angioplasty: what next? |
| Q41345678 | Percutaneous transluminal stent placement in the abdominal aorta |
| Q72341510 | Perioperative nursing interventions for intravascular stent placements |
| Q41178484 | Peripheral atherectomy: experimental results with a new device |
| Q30323095 | Periprocedural quantitative coronary angiography after Palmaz-Schatz stent implantation predicts the restenosis rate at six months: results of a meta-analysis of the BElgian NEtherlands Stent study (BENESTENT) I, BENESTENT II Pilot, BENESTENT II and |
| Q40904629 | Permanent vascular access: a nephrologist's view |
| Q38101963 | Pharmacotherapy for the reduction of stent thrombosis |
| Q34007517 | Platelet surface physiology and its importance in pharmacotherapy design and development: the adenosine diphosphate receptor antagonists |
| Q40589706 | Polymeric endoluminal paving. A family of evolving methods for extending endoluminal therapeutics beyond stenting. |
| Q37676695 | Preclinical models of restenosis and their application in the evaluation of drug-eluting stent systems |
| Q57807307 | Predictors of coronary in-stent restenosis: importance of angiotensin-converting enzyme gene polymorphism and treatment with angiotensin-converting enzyme inhibitors |
| Q42080298 | Predictors, therapeutic options and long-term outcome of abrupt reclosure |
| Q78106582 | Prevention of restenosis after stenting |
| Q38346245 | Prevention of stent thrombosis: challenges and solutions. |
| Q33699864 | Primary stenting and glycoprotein IIb/IIIa inhibitors in acute myocardial infarction |
| Q48865204 | Progress in cardiovascular care: a heart-felt thanks to our forebears. |
| Q36684479 | Promoting vascular regeneration as an alternative to conventional angioplasty-based intervention |
| Q36750497 | Prophylactic endovascular radiotherapy to prevent intimal hyperplasia after stent implantation in femoropopliteal arteries |
| Q67746873 | Quantitative angiographic follow-up of the coronary Wallstent in native vessels and bypass grafts (European experience — March 1986 to March 1990) |
| Q39399270 | Quantitative coronary angiography (QCA) in interventional cardiology: clinical application of QCA measurements. |
| Q78068746 | Radial force and wall apposition of balloon-expandable vascular stents in eccentric stenoses: an in vitro evaluation in a curved vessel model |
| Q74316138 | Randomized study to compare PTA alone versus PTA with Palmaz stent placement for femoropopliteal lesions |
| Q38034175 | Recent insights into the biomedical applications of shape-memory polymers |
| Q40463337 | Repeat Dilation of Intravascular Stents in Congenital Heart Defects |
| Q37930965 | Restenosis after PCI. Part 1: pathophysiology and risk factors |
| Q70053048 | Restenosis after percutaneous transluminal coronary angioplasty |
| Q38140546 | Restenosis following coronary angioplasty |
| Q73028187 | Restenosis of endovascular stents from stent compression |
| Q35655575 | Revascularization therapy for coronary artery disease. Coronary artery bypass grafting versus percutaneous transluminal coronary angioplasty |
| Q38563916 | Role of Animal Models in Coronary Stenting |
| Q73599585 | Role of intracoronary ultrasound after high-pressure stent implantation |
| Q74773980 | Role of intravascular ultrasound in the evaluation of mechanisms of coronary interventions and restenosis |
| Q36924394 | Role of the soluble pattern recognition receptor PTX3 in vascular biology |
| Q73209628 | Rupture of coronary artery and cardiac tamponade complicating Wallstent implantation |
| Q73591638 | Safety and efficacy of angiography-guided stent placement in small native coronary arteries of < 3.0 mm in diameter |
| Q33614126 | Self expanding stents for the management of aorto-ostial stenoses in saphenous vein bypass grafts |
| Q33614212 | Self expanding stents in congenital heart disease |
| Q41200026 | Self-expandable nitinol coil stent for management of colonic obstruction due to a malignant anastomotic stricture |
| Q69194083 | Self-expanding stents for the treatment of a long venous stenosis in a dialysis shunt: case report |
| Q51635934 | Self-expanding tracheobronchial stents using flexible bronchoscopy. Preliminary clinical experience. |
| Q42071527 | Short and long term outcome of percutaneous transluminal coronary angioplasty in unstable versus stable angina pectoris: a report of the 1985-1986 NHLBI PTCA Registry |
| Q33611664 | Short and long term results after intracoronary stenting in human coronary arteries: monocentre experience with the balloon-expandable Palmaz-Schatz stent |
| Q77681900 | Single and tandem stents in sheep iliac arteries: is there a difference in patency? |
| Q88992134 | Singularity now: using the ventricular assist device as a model for future human-robotic physiology |
| Q41734239 | Sirolimus blocks the accumulation of hyaluronan (HA) by arterial smooth muscle cells and reduces monocyte adhesion to the ECM |
| Q28206536 | Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary Artery |
| Q57044145 | Six months versus 12 months dual antiplatelet therapy after drug-eluting stent implantation in ST-elevation myocardial infarction (DAPT-STEMI): randomised, multicentre, non-inferiority trial |
| Q40938633 | Some thoughts on the present and future of coronary artery stenting |
| Q42061375 | Stand-by versus stent-by during percutaneous transluminal coronary angioplasty |
| Q71656205 | Stent embolization during intracoronary stenting |
| Q30450292 | Stent fracture: how frequently is it recognized? |
| Q33689494 | Stent grafts in occlusive arterial disease |
| Q41951133 | Stent implantation in congenital heart disease |
| Q78194761 | Stent or angioplasty after recanalization of chronic coronary occlusions? (The SARECCO Trial) |
| Q39248744 | Stent placement for failed angioplasty of aortic stenoses: Report of two cases |
| Q39437333 | Stent placement for treatment of mesenteric artery stenoses or occlusions |
| Q26785321 | Stent thrombosis and restenosis: what have we learned and where are we going? The Andreas Grüntzig Lecture ESC 2014 |
| Q34007532 | Stent thrombosis: historical perspectives and current trends |
| Q51042350 | Stented artery biomechanics and device design optimization. |
| Q73668422 | Stenting for acute myocardial infarction |
| Q71776368 | Stenting in Chronic Coronary Occlusion (SICCO): a randomized, controlled trial of adding stent implantation after successful angioplasty |
| Q35366570 | Stenting of "unprotected" left main coronary artery stenoses: early and late results |
| Q73189825 | Stenting the stent: initial results and long-term clinical and angiographic outcome of coronary stenting for patients with in-stent restenosis |
| Q37786646 | Stents and statins: history, clinical outcomes and mechanisms |
| Q71607013 | Stents wrapped in autologous vein: an experimental study |
| Q40589696 | Structural design, clinical experience, and current indications of the coronary Wallstent. |
| Q41073641 | Subacute stent thrombosis and the anticoagulation controversy: changes in drug therapy, operator technique, and the impact of intravascular ultrasound. |
| Q72809487 | Subacute thrombotic complications after intracoronary implantation of Palmaz-Schatz stents |
| Q33611872 | Successful stenting of a life threatening pulmonary arterial stenosis |
| Q41458479 | Superior vena cava obstruction: a modern management strategy |
| Q73840808 | Suramin inhibits proliferation of human arterial smooth muscle cells in vitro: potential drug for prevention of restenosis by local drug delivery |
| Q58699600 | Surface Finish and Back-Wall Dross Behavior during the Fiber Laser Cutting of AZ31 Magnesium Alloy |
| Q38040738 | Surface chemical and physical modification in stent technology for the treatment of coronary artery disease |
| Q41634009 | Surface modification of endovascular stents with rosuvastatin and heparin-loaded biodegradable nanofibers by electrospinning |
| Q38262668 | Surgical versus percutaneous revascularization in patients with multivessel coronary artery disease |
| Q53947625 | Sustained benefit of stenting chronic coronary occlusion: long-term clinical follow-up of the Stenting in Chronic Coronary Occlusion (SICCO) study. |
| Q37102287 | Techniques in Vascular and Interventional Radiology Drug Delivery Technologies in the Superficial Femoral Artery |
| Q50989450 | Temporary scaffolding of coronary arteries with bioabsorbable magnesium stents: a prospective, non-randomised multicentre trial. |
| Q36813356 | Temporary stent as a bail-out device during percutaneous transluminal coronary angioplasty: preliminary clinical experience |
| Q54392178 | Temporary tracheobronchial stenting in malignant stenoses. |
| Q54163283 | Ten-year clinical and angiographic follow-up of coronary wallstent. |
| Q93052439 | The Current State of MicroRNAs as Restenosis Biomarkers |
| Q56945558 | The Stentor and the sea change |
| Q45129030 | The Strecker stent: indications and results in iliac and femoropopliteal arteries |
| Q38938943 | The Use and Outcomes of Small, Medium and Large Premounted Stents in Pediatric and Congenital Heart Disease |
| Q48603262 | The acute effect of stenting with the nitinol self-expanding coil stent: preliminary experience |
| Q43241616 | The application of electrostatic dry powder deposition technology to coat drug-eluting stents |
| Q83475236 | The bioabsorbable stent as a virtual prosthesis |
| Q48115207 | The dawn of neurosurgery in pre-conquest Mesoamerican territories |
| Q36037446 | The intra-vascular stent as a site-specific local drug delivery system |
| Q35750263 | The never-ending story of peptide O-xylosyltransferase. |
| Q28200757 | The safety and efficacy of aspirin and clopidogrel as a combination treatment in patients with coronary heart disease |
| Q52234466 | The stent decade: 1987 to 1997. Stanford Stent Summit faculty. |
| Q53455081 | The stent revolution: has the peak been reached? |
| Q42788329 | The story of 'STENT': From noun to verb |
| Q54176210 | The use of expandable metal stents in transplant renal artery stenosis. |
| Q72614149 | The use of the Wallstent in aorto-iliac vascular disease |
| Q35117070 | Therapeutic potential of active stent coating |
| Q68437641 | Thrombogenicity of metallic vascular stents in arteries and veins--an experimental study in pigs |
| Q40999493 | Thrombotic and Hemorrhagic Complications of Stenting Coronary Arteries: Incidence, Management, and Prevention |
| Q28191104 | Ticlopidine versus oral anticoagulation for coronary stenting |
| Q77220861 | Timing of coronary stent thrombosis in patients treated with ticlopidine and aspirin |
| Q38265789 | Titania nanotube arrays for local drug delivery: recent advances and perspectives |
| Q58611990 | Towards non-invasive characterisation of coronary stent re-endothelialisation - An in-vitro, electrical impedance study |
| Q73875422 | Tracheobronchial Wallstents for degenerated saphenous vein bypass grafts |
| Q42080433 | Transluminal intracoronary reperfusion catheter: a device to maintain coronary perfusion between failed coronary angioplasty and emergency coronary bypass surgery |
| Q46382282 | Treatment of a coronary bifurcation lesion with drug-coated balloons: lumen enlargement and plaque modification after 6 months |
| Q72116395 | Treatment of acute aortic dissections with expandable metallic stents: experimental study |
| Q72586173 | Treatment of aortic dissections with a percutaneous intravascular endoprosthesis: comparison of covered and bare stents |
| Q42115737 | Treatment of coronary artery disease from the inside: Light at the end of the tunnel? |
| Q46782399 | Treatment of in-stent restenosis with sirolimus-eluting-stents -- a six month clinical and angiographic follow-up. |
| Q46720487 | Treatment of in-stent restenosis with sirolimus-eluting-stents: results from the prospective German Cypher stent registry |
| Q74823674 | Treatment of recurrent transplant renal artery stenosis with metallic stents |
| Q33751416 | Treatment options for coronary stent restenosis |
| Q33373964 | Trends in endovascular surgery. |
| Q42456587 | Tumor necrosis factor alpha and interleukin 10 promoter polymorphisms in Mexican patients with restenosis after coronary stenting |
| Q48517848 | Ulrich Sigwart. |
| Q70510990 | Ultrafast computed tomographic scanning to assess patency of coronary artery stents in bypass grafts |
| Q28287871 | Unconstrained recovery characterization of shape-memory polymer networks for cardiovascular applications |
| Q56945481 | Uncoupling clinical outcomes and coronary angiography: A review and perspective of recent trials in coronary artery disease |
| Q40484396 | Urologic applications of a permanent, epithelializing urethral endoprosthesis |
| Q72229996 | Urolume endourethral prosthesis for the treatment of urethral stricture disease: long-term results of the North American Multicenter UroLume Trial |
| Q46834584 | Urolume urethral wallstent in the treatment of detrusor sphincter dyssynergia |
| Q68032894 | Use of an intravascular endoprosthesis (stent) to establish and maintain short-term patency of the ductus arteriosus in newborn lambs |
| Q34707405 | Use of prostatic stents for the treatment of benign prostatic hyperplasia in high-risk patients |
| Q34562467 | Use of the Gianturco Self-expanding Stent in Stenoses of the Superior and Inferior Venae Cavae |
| Q73031080 | Vale, warfarin: a stentorian farewell |
| Q35583198 | Vascular brachytherapy versus sirolimus eluting stents for the treatment of in-stent restenosis: a prospective registry |
| Q39514871 | Wallstent endoprostheses for the relief of prostatic urethral obstruction in high risk patients |
| Q53588881 | What is a stent and where can you get one? |
| Q37472070 | Xience V everolimus-eluting coronary stent |
| Q34333105 | Zinc exhibits ideal physiological corrosion behavior for bioabsorbable stents |
| Q85867313 | [Antithrombocytic therapy and PCI. Duration of therapy after DCB/stents/scaffolds] |
| Q83908065 | [Coronary stent thrombosis: what's new in 2011?] |
| Q53292005 | [Imaging of coronary stents using multislice computed tomography]. |
| Q77470727 | [Implications of late expansion of self-expanding stents on neointimal response: a serial study with intravascular ultrasound] |
| Q80592180 | [Surgical treatment of neurogenic urinary sphincter dysfunction] |
| Q80411496 | [Treatment of coronary disease] |
| Q34504964 | microRNAs Distinctively Regulate Vascular Smooth Muscle and Endothelial Cells: Functional Implications in Angiogenesis, Atherosclerosis, and In-Stent Restenosis |